Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat

[1]  S. Tremblay,et al.  Hormonal Regulation of Estradiol 17β‐Hydroxysteroid Dehydrogenase Activity in the ZR‐75‐1 Human Breast Cancer Cell Line , 1990 .

[2]  M. Dumont,et al.  Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. , 1989, Endocrinology.

[3]  J. Simard,et al.  Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. , 1989, Molecular endocrinology.

[4]  F. Labrie,et al.  Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. , 1988, Journal of steroid biochemistry.

[5]  F. Labrie,et al.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line , 1988, Breast Cancer Research and Treatment.

[6]  B. Marchetti,et al.  Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate. , 1988, Journal of steroid biochemistry.

[7]  C. Labrie,et al.  Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. , 1988, Endocrinology.

[8]  F. Labrie,et al.  Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. , 1988, Journal of steroid biochemistry.

[9]  C. Labrie,et al.  Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer. , 1987, Journal of steroid biochemistry.

[10]  D. Chalbos,et al.  Identification and androgen regulation of two proteins released by T47D human breast cancer cells. , 1987, Cancer research.

[11]  J. Simard,et al.  Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues , 1986, Molecular and Cellular Endocrinology.

[12]  C. Welsch.  Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. , 1985, Cancer research.

[13]  F. Hölzel,et al.  In vitro modulation of prolactin binding to human mammary carcinoma cells by steroid hormones and prolactin. , 1985, The Journal of clinical endocrinology and metabolism.

[14]  R. Bryan,et al.  Androgen receptors in breast cancer , 1984, Cancer.

[15]  B. Edwards,et al.  Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. , 1983, Annals of internal medicine.

[16]  J. MacIndoe,et al.  An antiestrogenic action of androgens in human breast cancer cells. , 1981, The Journal of clinical endocrinology and metabolism.

[17]  M Brunet,et al.  Relationship of presence of progesterone receptors to prognosis in early breast cancer. , 1980, Cancer research.

[18]  A. Bélanger,et al.  Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control. , 1980, Cancer research.

[19]  F. Labrie,et al.  Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. , 1978, Journal of steroid biochemistry.

[20]  H. Rochefort,et al.  Androgen effects mediated by estrogen receptor in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. , 1978, Cancer research.

[21]  W. McGuire,et al.  Androgen action through estrogen receptor in a human breast cancer cell line. , 1978, Endocrinology.

[22]  W. McGuire,et al.  Human breast cancer: androgen action mediated by estrogen receptor. , 1978, Science.

[23]  M. Caron,et al.  Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. , 1977, Endocrinology.

[24]  W. McGuire,et al.  Estrogen receptors in androgen-induced breast tumor regression. , 1977, Cancer research.

[25]  Marcel Garcia,et al.  Androgens on the estrogen receptor II — correlation between nuclear translocation and uterine protein synthesis , 1977, Steroids.

[26]  W. McGuire,et al.  Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma. , 1976, Cancer research.

[27]  Gordon Hiroshi Sasaki,et al.  Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors. , 1975, Cancer research.

[28]  J. Meites,et al.  Counteraction by prolactin of androgen-induced inhibition of mammary tumor growth in rats. , 1974, Journal of the National Cancer Institute.

[29]  A. Forrest,et al.  Steroid metabolism by human breast and rat mammary carcinomata. , 1974, Steroids.

[30]  R. Neri,et al.  A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide). , 1972, Endocrinology.

[31]  B. Mobbs.  The effect of testosterone treatment on the uptake of [3H] oestradiol-17 beta by dimethylbenzanthracene-induced rat mammary tumours. , 1970, The Journal of endocrinology.

[32]  C. Stock,et al.  Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system. , 1968, Cancer research.

[33]  M. Görlich,et al.  Growth and therapy of mammary tumours induced by 7,12-dimethylbenzanthracene in rats. , 1966, British Journal of Cancer.

[34]  C. Stock,et al.  Biologic characteristics and chemotherapy of 7,12-dimethylbenz[a]anthracene-induced tumors in rats. , 1966, Cancer research.

[35]  S. Young,et al.  The Effects of Androgens on Induced Mammary Tumours in Rats , 1965, British Journal of Cancer.

[36]  Gol'denberg Is.  TESTOSTERONE PROPIONATE THERAPY IN BREAST CANCER. , 1964 .

[37]  H. Sutton,et al.  RAPID INDUCTION OF MAMMARY CARCINOMA IN THE RAT AND THE INFLUENCE OF HORMONES ON THE TUMORS , 1959, The Journal of experimental medicine.

[38]  B. Kennedy.  Fluoxymesterone therapy in advanced breast cancer. , 1958, The New England journal of medicine.

[39]  K. Mainzer,et al.  HORMONAL INFLUENCES ON MAMMARY TUMORS OF THE RAT , 1957, The Journal of experimental medicine.

[40]  Clyde Young Kramer,et al.  Extension of multiple range tests to group means with unequal numbers of replications , 1956 .

[41]  E. Jensen,et al.  CHEMICAL STRUCTURE OF STEROIDS IN RELATION TO PROMOTION OF GROWTH OF THE VAGINA AND UTERUS OF THE HYPOPHYSECTOMIZED RAT , 1954, The Journal of experimental medicine.

[42]  A. Segaloff,et al.  Hormonal therapy in cancer of the breast. VI. Effect of ACTH and cortisone on clinical course and hormonal excretion , 1954, Cancer.

[43]  T. Antoine.  [Hormone therapy in cancer of the breast]. , 1951, Wiener Klinische Wochenschrift.

[44]  E. Fels.  Treatment of Breast Cancer with Testosterone Propionate , 1944 .

[45]  E B Wilson,et al.  On Contingency Tables. , 1942, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Labrie,et al.  Androstenedione and androst-5-ene-3β,17β-diol stimulate DMBA-induced rat mammary tumors — role of aromatase , 2005, Breast Cancer Research and Treatment.

[47]  E. Shapiro,et al.  Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion. , 1985, Journal of steroid biochemistry.

[48]  H. Rochefort,et al.  The estrogenic and antiestrogenic activities of androgens in female target tissues. , 1983, Pharmacology & therapeutics.

[49]  C. Meijer,et al.  Estrogen receptors in human breast cancer , 1982 .

[50]  G. Trams,et al.  Specific binding of estradiol and dihydrotestosterone in human mammary cancers. , 1977, Cancer research.

[51]  A. Segaloff.  The use of androgens in the treatment of neoplastic disease , 1977 .

[52]  R. Hilf.  Anabolic-Androgenic Steroids and Experimental Mammary Tumors , 1976 .

[53]  G. Gordan.  Cancer in Man , 1976 .

[54]  R. J. Parsons,et al.  Calusterone (7β,17α-DimethyItestosterone) as Primary and Secondary Therapy of Advanced Breast Cancer , 1973 .

[55]  I. S. Goldenberg.  TESTOSTERONE PROPIONATE THERAPY IN BREAST CANCER. , 1964, JAMA.